Early diagnosis
makes a difference.
ONCOCAN TEST
Detección temprana de múltiples cáncers caninos haciendo uso de análisis de secuenciación masiva (NGS) y algoritmos bioinformáticos propios.
Nuestra tecnología permite examinar detalladamnete el ADN de los perros para identificar biomarcadores genéticos en sangre vinculados a diversos tipos de cáncer.
Con Oncotest, se abren nuevas vías en el diagnóstico y tratamiento del cáncer en perros, facilitando una intervención más temprana y eficaz.
.
OmiCare AI
Revolutionising Veterinary Oncological Diagnosis.
OMICARE AI is an innovative artificial intelligence platform that transforms cancer diagnosis in pets. It integrates genomic data, clinical information, and medical imaging to provide accurate diagnoses about the type and progression of tumors.
This unique tool personalises oncological treatment, making a significant difference in veterinary medicine with solutions tailored to each patient.”
With OMICARE AI, Omica Biomed is pioneering new paths toward optimal care for cancer patients.
.
GenTest
Gentest is a genetic testing service specifically designed for veterinary use. This test analyses an animal’s DNA to identify genetic differences or mutations that may predispose them to certain diseases, including hereditary disorders and cancers.
We utilize advanced technology that enables us to analyze multiple diseases from a single sample.
Each sample undergoes a comprehensive genetic disease panel analysis. This high-throughput technology requires only a small volume of consumables, allowing us to reduce costs significantly.
.
.
¿How does it work?
Quick, painless, and simple..
From a simple blood or saliva sample.